{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:25:59Z","timestamp":1783113959208,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11739-018-1842-x","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T04:51:16Z","timestamp":1523249476000},"page":"475-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism"],"prefix":"10.1007","volume":"13","author":[{"given":"Antonio","family":"Brucato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Bar\u00f3n-Esquivias G, Bogaert J et al (2015) ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921\u20132964. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"1842_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jama.2015.12763","volume":"314","author":"M Imazio","year":"2015","unstructured":"Imazio M, Gaita F, LeWinter M (2015) Evaluation and treatment of pericarditis: a systematic review. JAMA 314:1498\u20131506. \n                    https:\/\/doi.org\/10.1001\/jama.2015.12763","journal-title":"JAMA"},{"key":"1842_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjcard.2006.01.086","volume":"98","author":"A Brucato","year":"2006","unstructured":"Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A et al (2006) Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 98:267\u2013271","journal-title":"Am J Cardiol"},{"key":"1842_CR4","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M et al (2016) Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA 316:1906\u20131912. \n                    https:\/\/doi.org\/10.1001\/jama.2016.15826","journal-title":"JAMA"},{"key":"1842_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvx018","author":"L Buckley","year":"2017","unstructured":"Buckley L, Viscusi MM, Van Tassell B, Abbate A (2017) Interleukin-1 blockade for the treatment of pericarditis. Eur Heart J Cardiovasc Pharmacother. \n                    https:\/\/doi.org\/10.1093\/ehjcvp\/pvx018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1842_CR6","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1056\/NEJMcp1404070","volume":"371","author":"MM LeWinter","year":"2014","unstructured":"LeWinter MM (2014) Clinical practice. Acute pericarditis. N Engl J Med 371:2410\u20132416. \n                    https:\/\/doi.org\/10.1093\/ehjcvp\/pvx018","journal-title":"N Engl J Med"},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/heartjnl-2014-306362","volume":"2101","author":"M Imazio","year":"2015","unstructured":"Imazio M, Gaita F (2015) Diagnosis and treatment of pericarditis. Heart 2101:1159\u20131168. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2014-306362","journal-title":"Heart"},{"issue":"6","key":"1842_CR8","doi-asserted-by":"publisher","first-page":"e001483","DOI":"10.1161\/JAHA.114.001483","volume":"3","author":"D Shakti","year":"2014","unstructured":"Shakti D, Hehn R, Gauvreau K, Sundel RP, Newburger JW (2014) Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc 7 3(6):e001483. \n                    https:\/\/doi.org\/10.1161\/jaha.114.001483","journal-title":"J Am Heart Assoc 7"},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.114.010376","volume":"130","author":"V Kyt\u00f6","year":"2014","unstructured":"Kyt\u00f6 V, Sipil\u00e4 J, Rautava P (2014) Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 130:1601\u20131606. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA114.010376","journal-title":"Circulation"},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/hrt.2006.104067","volume":"94","author":"M Imazio","year":"2008","unstructured":"Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D et al (2008) Myopericarditis versus viral or idiopathic acute pericarditis. Heart Br Card Soc 94:498\u2013501. \n                    https:\/\/doi.org\/10.1136\/hrt.2006.104067","journal-title":"Heart Br Card Soc"},{"issue":"136","key":"1842_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/CIRCULATIONAHA.116.024041","volume":"12","author":"KK S\u00f8gaard","year":"2017","unstructured":"S\u00f8gaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, B\u00f8tker HE, S\u00f8rensen HT (2017) Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation 12(136):996\u20131006. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024041","journal-title":"Circulation"},{"issue":"369","key":"1842_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","volume":"17","author":"M Imazio","year":"2013","unstructured":"Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F et al (2013) A randomized trial of colchicine for acute pericarditis. N Engl J Med 17(369):1522\u20131528. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1208536","journal-title":"N Engl J Med"},{"key":"1842_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","volume":"155","author":"M Imazio","year":"2011","unstructured":"Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S et al (2011) Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 155:409\u2013414. \n                    https:\/\/doi.org\/10.7326\/0003-4819-155-7-201110040-00359","journal-title":"Ann Intern Med"},{"key":"1842_CR14","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","volume":"165","author":"M Imazio","year":"2005","unstructured":"Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987\u20131991. \n                    https:\/\/doi.org\/10.1001\/archinte.165.17.1987","journal-title":"Arch Intern Med"},{"key":"1842_CR15","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","volume":"383","author":"M Imazio","year":"2014","unstructured":"Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F et al (2014) Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet Lond Engl 383:2232\u20132237. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)62709-9","journal-title":"Lancet Lond Engl"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.jacc.2017.02.072","volume":"69","author":"A Brucato","year":"2017","unstructured":"Brucato A, Valenti A, Maisch B (2017) Acute and recurrent\u00a0pericarditis: still idiopathic? J Am Coll Cardiol 69:2775. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.02.072","journal-title":"J Am Coll Cardiol"},{"issue":"68","key":"1842_CR17","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.jacc.2016.07.785","volume":"29","author":"PC Cremer","year":"2016","unstructured":"Cremer PC, Kumar A, Kontzias A, Tan CD, Rodriguez ER, Imazio M et al (2016) Complicated pericarditis: understanding risk factors and pathophysiology to\u00a0inform\u00a0imaging and treatment. J Am Coll Cardiol 29(68):2311\u20132328. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2016.07.785","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1586\/1744666X.2014.965150","volume":"10","author":"M Imazio","year":"2014","unstructured":"Imazio M (2014) Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev Clin Immunol 10:1487\u20131492. \n                    https:\/\/doi.org\/10.1586\/1744666X.2014.965150","journal-title":"Expert Rev Clin Immunol"},{"key":"1842_CR19","doi-asserted-by":"publisher","DOI":"10.2174\/1573397113666170704102444","author":"MB Urowitz","year":"2017","unstructured":"Urowitz MB, Tselios K (2017) Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. \n                    https:\/\/doi.org\/10.2174\/1573397113666170704102444","journal-title":"Curr Rheumatol Rev"},{"key":"1842_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ijcard.2011.01.027","volume":"147","author":"F Vianello","year":"2011","unstructured":"Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S et al (2011) Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 147:477\u2013478. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2011.01.027","journal-title":"Int J Cardiol"},{"key":"1842_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2459\/JCM.0000000000000300","volume":"17","author":"M Imazio","year":"2016","unstructured":"Imazio M, Brucato A, Pluymaekers N, Breda L, Calabri G, Cantarini L et al (2016) Recurrent pericarditis in children and adolescents: a multicentre cohort study. J Cardiovasc Med Hagerstown Md 17:707\u2013712. \n                    https:\/\/doi.org\/10.2459\/JCM.0000000000000300","journal-title":"J Cardiovasc Med Hagerstown Md"},{"key":"1842_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/hrt.2009.187138","volume":"96","author":"ALP Caforio","year":"2010","unstructured":"Caforio ALP, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A et al (2010) Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart Br Card Soc 96:779\u2013784. \n                    https:\/\/doi.org\/10.1136\/hrt.2009.187138","journal-title":"Heart Br Card Soc"},{"key":"1842_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.autrev.2012.07.023","volume":"12","author":"S Maestroni","year":"2012","unstructured":"Maestroni S, Di Corato PR, Cumetti D, Chiara DBLC, Ghidoni S, Prisacaru L et al (2012) Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 12:60\u201365. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2012.07.023","journal-title":"Autoimmun Rev"},{"key":"1842_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10067-014-2721-0","volume":"34","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L et al (2015) The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol 34:17\u201328. \n                    https:\/\/doi.org\/10.1007\/s10067-014-2721-0","journal-title":"Clin Rheumatol"},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.autrev.2014.08.001","volume":"13","author":"D Rigante","year":"2014","unstructured":"Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 13:892\u2013900. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2014.08.001","journal-title":"Autoimmun Rev"},{"key":"1842_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11739-016-1466-y","volume":"11","author":"M Cattalini","year":"2016","unstructured":"Cattalini M, Soliani M, Lopalco G, Rigante D, Cantarini L (2016) Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists\u2019 lens. Intern Emerg Med 11:781\u2013791. \n                    https:\/\/doi.org\/10.1007\/s11739-016-1466-y","journal-title":"Intern Emerg Med"},{"key":"1842_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2017.00043","volume":"8","author":"C Torre-Minguela de","year":"2017","unstructured":"de Torre-Minguela C, Mesa Del Castillo P, Pelegr\u00edn P (2017) The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol 8:43. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00043","journal-title":"Front Immunol"},{"key":"1842_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1191\/0961203305lu2197oa","volume":"14","author":"A Brucato","year":"2005","unstructured":"Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC et al (2005) Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 14:670\u2013674. \n                    https:\/\/doi.org\/10.1191\/0961203305lu2197oa","journal-title":"Lupus"},{"key":"1842_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","volume":"101","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F et al (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol Off J Ger Card Soc 101:525\u2013531. \n                    https:\/\/doi.org\/10.1007\/s00392-012-0422-8","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"1842_CR30","first-page":"297","volume":"32","author":"G Emmi","year":"2014","unstructured":"Emmi G, Barnini T, Silvestri E, Milco D\u2019Elios M, Emmi L, Prisco D (2014) A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions. Clin Exp Rheumatol 32:297 Epub 2013 Dec 2","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR31","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/art.10429","volume":"46","author":"C Dod\u00e9","year":"2002","unstructured":"Dod\u00e9 C, Andr\u00e9 M, Bienvenu T, Hausfater P, P\u00eacheux C, Bienvenu J et al (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181\u20132188. \n                    https:\/\/doi.org\/10.1002\/art.10429","journal-title":"Arthritis Rheum"},{"key":"1842_CR32","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","volume":"73","author":"HJ Lachmann","year":"2014","unstructured":"Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L et al (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann Rheum Dis 73:2160\u20132167. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204184","journal-title":"Ann Rheum Dis"},{"key":"1842_CR33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.108.844753","volume":"121","author":"M Imazio","year":"2010","unstructured":"Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010) Controversial issues in the management of pericardial diseases. Circulation 121:916\u2013928. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.844753","journal-title":"Circulation"},{"key":"1842_CR34","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","volume":"115","author":"M Imazio","year":"2007","unstructured":"Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A et al (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739\u20132744. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.662114","journal-title":"Circulation"},{"key":"1842_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2459\/JCM.0000000000000358","volume":"17","author":"M Imazio","year":"2016","unstructured":"Imazio M, Brucato A, Badano L, Charron P, Adler Y (2016) What\u2019s new in 2015 ESC guidelines on pericardial diseases? J Cardiovasc Med Hagerstown Md 17:315\u2013322. \n                    https:\/\/doi.org\/10.2459\/JCM.0000000000000358","journal-title":"J Cardiovasc Med Hagerstown Md"},{"issue":"3","key":"1842_CR36","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.ijcard.2014.01.029","volume":"172","author":"P Vasileiou","year":"2014","unstructured":"Vasileiou P, Tsioufis C, Lazaros G, Hadziyannis E, Kasiakogias A, Stefanadis C et al (2014) Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Cardiol 1 172(3):e463\u2013e464. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2014.01.029","journal-title":"A pilot study. Int J Cardiol 1"},{"key":"1842_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1586\/erc.09.82","volume":"7","author":"M Imazio","year":"2009","unstructured":"Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y (2009) Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther 7:965\u2013975. \n                    https:\/\/doi.org\/10.1586\/erc.09.82","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1842_CR38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","volume":"118","author":"M Imazio","year":"2008","unstructured":"Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667\u2013671. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.761064","journal-title":"Circulation"},{"issue":"112","key":"1842_CR39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.amjcard.2013.06.036","volume":"1","author":"M Moretti","year":"2013","unstructured":"Moretti M, Buiatti A, Merlo M, Massa L, Fabris E, Pinamonti B et al (2013) Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 1(112):1493\u20131498. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2013.06.036","journal-title":"Am J Cardiol"},{"key":"1842_CR40","first-page":"788","volume":"31","author":"S Gaspari","year":"2013","unstructured":"Gaspari S, Marsili M, Imazio M, Brucato A, Di Blasi Lo Cuccio C, Chiarelli F et al (2013) New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children. Clin Exp Rheumatol 31:788\u2013794 (epub 2 Aug 2013)","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR41","first-page":"945","volume":"33","author":"G Lazaros","year":"2015","unstructured":"Lazaros G, Vasileiou P, Danias P, Koutsianas C, Vlachopoulos C, Tousoulis D et al (2015) Effusive-constrictive pericarditis successfully treated with anakinra. Clin Exp Rheumatol 33:945 Epub 2015 Oct 30","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR42","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/0735-1097(95)00302-9","volume":"26","author":"R Marcolongo","year":"1995","unstructured":"Marcolongo R, Russo R, Laveder F, Noventa F, Agostini C (1995) Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 26:1276\u20131279. \n                    https:\/\/doi.org\/10.1016\/0735-1097(95)00302-9","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0735-1097(03)00778-2","volume":"42","author":"M Raatikka","year":"2003","unstructured":"Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV (2003) Recurrent pericarditis in children and adolescents: report of 15 cases. J Am Coll Cardiol 42:759\u2013764","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4065\/mcp.2010.0046","volume":"85","author":"MH Khandaker","year":"2010","unstructured":"Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM et al (2010) Pericardial disease: diagnosis and management. Mayo Clin Proc 85:572\u2013593. \n                    https:\/\/doi.org\/10.4065\/mcp.2010.0046","journal-title":"Mayo Clin Proc"},{"key":"1842_CR45","first-page":"93","volume":"17","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Lopalco G, Cattalini M, Vitale A, Galeazzi M, Rigante D (2015) Interleukin-1: Ariadne\u2019s thread in autoinflammatory and autoimmune disorders. Isr Med Assoc J IMAJ 17:93\u201397","journal-title":"Isr Med Assoc J IMAJ"},{"key":"1842_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","volume":"35","author":"G Emmi","year":"2016","unstructured":"Emmi G, Talarico R, Lopalco G, Cimaz R, Cantini F, Viapiana O et al (2016) Efficacy and safety profile of anti-interleukin-1 treatment in Beh\u00e7et\u2019s disease: a multicenter retrospective study. Clin Rheumatol 35:1281\u20131286. \n                    https:\/\/doi.org\/10.1007\/s10067-015-3004-0","journal-title":"Clin Rheumatol"},{"key":"1842_CR47","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fphar.2016.00380","volume":"7","author":"A Vitale","year":"2016","unstructured":"Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M et al (2016) A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a Nationwide Multi-Center Retrospective Observational Study. Front Pharmacol 7:380. \n                    https:\/\/doi.org\/10.3389\/fphar.2016.00380","journal-title":"Front Pharmacol"},{"key":"1842_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2017.00369","volume":"8","author":"S Colafrancesco","year":"2017","unstructured":"Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E et al (2017) Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still\u2019s disease: a Multicentre Retrospective Observational Study. Front Pharmacol 8:369. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00369","journal-title":"Front Pharmacol"},{"key":"1842_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S et al (2017) Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36:191\u2013197. \n                    https:\/\/doi.org\/10.1007\/s10067-016-3506-4","journal-title":"Clin Rheumatol"},{"key":"1842_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fmed.2017.00078","volume":"4","author":"G Lazaros","year":"2017","unstructured":"Lazaros G, Antonatou K, Vassilopoulos D (2017) The therapeutic role of interleukin-1 inhibition in idiopathic recurrent pericarditis: current evidence and future challenges. Front Med 4:78. \n                    https:\/\/doi.org\/10.3389\/fmed.2017.00078","journal-title":"Front Med"},{"key":"1842_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.24174","volume":"60","author":"P Picco","year":"2009","unstructured":"Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A (2009) Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum 60:264\u2013268. \n                    https:\/\/doi.org\/10.1002\/art.24174","journal-title":"Arthritis Rheum"},{"key":"1842_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2012.05.086","volume":"160","author":"D Vassilopoulos","year":"2012","unstructured":"Vassilopoulos D, Lazaros G, Tsioufis C, Vasileiou P, Stefanadis C, Pectasides D (2012) Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 160:66\u201368. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2012.05.086","journal-title":"Int J Cardiol"},{"key":"1842_CR53","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00246-013-0663-y","volume":"34","author":"M Camacho-Lovillo","year":"2013","unstructured":"Camacho-Lovillo M, M\u00e9ndez-Santos A (2013) Successful treatment of idiopathic recurrent pericarditis with interleukin-1 receptor antagonist (anakinra). Pediatr Cardiol 34:1293\u20131294. \n                    https:\/\/doi.org\/10.1007\/s00246-013-0663-y","journal-title":"Pediatr Cardiol"},{"key":"1842_CR54","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00246-012-0532-0","volume":"34","author":"A Scardapane","year":"2013","unstructured":"Scardapane A, Brucato A, Chiarelli F, Breda L (2013) Efficacy of an interleukin-1\u03b2 receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol 34:1989\u20131991. \n                    https:\/\/doi.org\/10.1007\/s00246-012-0532-0","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"1842_CR55","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.ijcard.2014.09.192","volume":"177","author":"C Massardier","year":"2014","unstructured":"Massardier C, Dauphin C, Eschalier R, Lusson JR, Soubrier M (2014) Resistant or recurrent acute pericarditis: a new therapeutic opportunity? Int J Cardiol 177(2):e75\u2013e77. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.192","journal-title":"Int J Cardiol"},{"key":"1842_CR56","first-page":"802","volume":"28","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Galeazzi M (2010) Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol 28:802 Epub 2010 Oct 22","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR57","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/1756-185X.13029","volume":"20","author":"D Camprub\u00ed","year":"2017","unstructured":"Camprub\u00ed D, Mitjavila F, Arostegui JI, Corbella X (2017) Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant. Int J Rheum Dis 20:510\u2013514. \n                    https:\/\/doi.org\/10.1111\/1756-185X.13029","journal-title":"Int J Rheum Dis"},{"key":"1842_CR58","first-page":"294","volume":"33","author":"E D\u2019Elia","year":"2015","unstructured":"D\u2019Elia E, Brucato A, Pedrotti P, Valenti A, De Amici M, Fiocca L et al (2015) Successful treatment of subacute constrictive pericarditis with interleukin-1\u03b2 receptor antagonist (anakinra). Clin Exp Rheumatol 33:294\u2013295 Epub 2015 Jan 29","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijcard.2016.08.131","volume":"223","author":"A Schatz","year":"2016","unstructured":"Schatz A, Trankle C, Yassen A, Chipko C, Rajab M, Abouzaki N et al (2016) Resolution of pericardial constriction with anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis. Int J Cardiol 223:215\u2013216. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.131","journal-title":"Int J Cardiol"},{"issue":"1425\u20131431","key":"1842_CR60","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jpeds.2014.01.065","volume":"164","author":"M Finetti","year":"2014","unstructured":"Finetti M, Insalaco A, Cantarini L, Meini A, Breda L, Alessio M et al (2014) Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr 164(1425\u20131431):e1. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2014.01.065","journal-title":"J Pediatr"},{"key":"1842_CR61","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.amjcard.2015.07.047","volume":"116","author":"S Jain","year":"2015","unstructured":"Jain S, Thongprayoon C, Espinosa RE, Hayes SN, Klarich KW, Cooper LT et al (2015) Effectiveness and safety of anakinra for management of refractory pericarditis. Am J Cardiol 116:1277\u20131279. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2015.07.047","journal-title":"Am J Cardiol"},{"key":"1842_CR62","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1136\/annrheumdis-2014-205990","volume":"73","author":"G Lazaros","year":"2014","unstructured":"Lazaros G, Vasileiou P, Koutsianas C, Antonatou K, Stefanadis C, Pectasides D et al (2014) Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis 73:2215\u20132217. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-205990","journal-title":"Ann Rheum Dis"},{"key":"1842_CR63","first-page":"531","volume":"34","author":"G Lopalco","year":"2016","unstructured":"Lopalco G, Rigante D, Giannini M, Galeazzi M, Lapadula G, Iannone F et al (2016) Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders. Clin Exp Rheumatol 34:531\u2013538 (epub 26 Feb 2016)","journal-title":"Clin Exp Rheumatol"},{"key":"1842_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/ijd.13337","volume":"56","author":"G Emmi","year":"2017","unstructured":"Emmi G, Silvestri E, Squatrito D, Vitale A, Bacherini D, Vannozzi L et al (2017) Long-term efficacy and safety of anakinra in a patient with Beh\u00e7et\u2019s disease and concomitant tuberculosis infection. Int J Dermatol 56:218\u2013220. \n                    https:\/\/doi.org\/10.1111\/ijd.13337","journal-title":"Int J Dermatol"},{"key":"1842_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.anai.2014.06.017","volume":"113","author":"S \u015eoyyi\u011fit","year":"2014","unstructured":"\u015eoyyi\u011fit S, Kendirlinan R, Ayd\u0131n O, \u00c7elik GE (2014) Successful desensitization with anakinra in a case with immediate hypersensitivity reaction. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 113:325\u2013326. \n                    https:\/\/doi.org\/10.1016\/j.anai.2014.06.017","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"key":"1842_CR66","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/1346-8138.13619","volume":"44","author":"G Emmi","year":"2017","unstructured":"Emmi G, Silvestri E, Cantarini L, Lopalco G, Cecchi L, Chiarini F et al (2017) Rapid desensitization to anakinra-related delayed reaction: need for a standardized protocol. J Dermatol 44:981\u2013982. \n                    https:\/\/doi.org\/10.1111\/1346-8138.13619","journal-title":"J Dermatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-018-1842-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1842-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1842-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:25:58Z","timestamp":1554769558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-018-1842-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s11739-018-1842-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}